Reportee | Signature Date | Report period | Total Entries | Total AUM($) |
---|---|---|---|---|
UBS OCONNOR LLC | 02-14-2024 | 12-31-2023 | 494 | 1,390,411,591,000 |
Issuer | Class | Position | Value | Shares | Portfolio Percentage (%) | Previous Percentage (%) | Shares Delta | Shares Delta(%) | Date Reported |
---|---|---|---|---|---|---|---|---|---|
PROLOGIS I | COM | 351 | $1,979,238,000 | 14,848 | 0.14 | 0.29 | -48,806 | -76.67 | 12-31-2023 |
TREACE MED | COM | 352 | $1,975,141,000 | 154,913 | 0.14 | 0.11 | 42,460 | 37.76 | 12-31-2023 |
INSULET CO | COM | 353 | $1,963,018,000 | 9,047 | 0.14 | 9,047 | +Inf | 12-31-2023 | |
GE HEALTHC | COMMO | 354 | $1,948,696,000 | 25,203 | 0.14 | 0.02 | 17,368 | 221.67 | 12-31-2023 |